---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-399425"
form_type: "8-K"
ticker: "JAZZ"
cik: "0001232524"
company_name: "Jazz Pharmaceuticals plc"
filed_at: "2026-09-23T20:15:16+00:00"
generated_at: "2026-09-23T20:16:23.600925+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Jazz extends $1.9B term loan to 2033, cuts margin by 50 bps

## Summary
- Jazz Lux amended credit agreement to extend $1,895,000,000 term loans maturity from May 5, 2028 to May 5, 2033.
- Interest margin reduced by 50 bps: now Term SOFR + 1.75% or prime + 0.75%, with 0.50% SOFR floor.
- Borrowed $273,310,355.18 new Tranche B-3 loans to repay non-converted Tranche B-2 loans; total principal unchanged at $1,895,000,000.
- Loans amortize quarterly at 0.25% of initial principal, balance due at new 2033 maturity.

## SEC filing metadata
- accession: 0001193125-26-399425
- form_type: 8-K
- ticker: JAZZ
- cik: 0001232524
- company_name: Jazz Pharmaceuticals plc
- filed_at: 2026-09-23T20:15:16+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1232524/000119312526399425/0001193125-26-399425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1232524/000119312526399425/d163027d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-399425
- JSON: https://secwatch.observer/filing/0001193125-26-399425.json
- Plain text: https://secwatch.observer/filing/0001193125-26-399425.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.